Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers
Status:
Completed
Trial end date:
2021-12-28
Target enrollment:
Participant gender:
Summary
This study is a comparative bioavailability study performed to assess bioequivalence between
Test medicinal product (Efez 50 mg eplerenone film-coated tablets manufactured by PrJSC
"Pharmaceutical firm "Darnitsa", Ukraine) and Reference medicinal product (marketed medicinal
product INSPRA® 50 mg eplerenone film-coated tablets, Marketing Authorisation Holder: Pfizer
Europe MA EEIG, Belgium) in healthy volunteers.